Dr. Federico is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
262 Danny Thomas Pl
Memphis, TN 38105Phone+1 901-595-3300Fax+1 901-521-9005
Education & Training
University of TennesseeFellowship, Pediatric Hematology/Oncology, 2007 - 2011
Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 2003 - 2006
Virginia Commonwealth University School of MedicineClass of 2003
Certifications & Licensure
CA State Medical License 2004 - Present
TN State Medical License 2006 - 2026
Clinical Trials
- Molecular Analysis Of Solid Tumors Start of enrollment: 2010 Feb 10
- Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Start of enrollment: 2019 Mar 04
- Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma Start of enrollment: 2021 Jun 09
- Join now to see all
Publications & Presentations
PubMed
- Treatment of a pediatric patient with concurrent neuroblastoma and acute lymphoblastic leukemia.Megan M Lilley, Marta Salek, Ashley Holland, Hiroto Inaba, Sara M Federico
Pediatric Blood & Cancer. 2024-12-01 - Genomic profiling of circulating tumor DNA for childhood cancers.Shaohua Lei, Sujuan Jia, Sunitha Takalkar, Ti-Cheng Chang, Xiaotu Ma
Leukemia. 2024-11-10 - Quantitative determination of liposomal irinotecan and SN-38 concentrations in plasma samples from children with solid tumors: Use of a cryoprotectant solution to enha...Sreenath Nair, Nicholas S Selvo, Abigail Stolarski, Brandon Klee, Sara M Federico
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 2024-09-15
Journal Articles
- Case Report: Management Approach and Use of Extracorporeal Membrane Oxygenation for Diffuse Alveolar Hemorrhage After Pediatric Hematopoietic Cell TransplantSara Federico, Amr Qudeimat, Frontiers in Pediatrics
Press Mentions
First Successful Treatment of Pediatric High-Risk Refractory Neuroblastoma with PARP InhibitionAugust 15th, 2024- 'Bridge' Therapy May Benefit Some Kids with High-Risk NeuroblastomaJune 22nd, 2022
Findings About Children’s Solid Tumors Are Sparking New TherapiesApril 9th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
